SKI Market

Indian Indices

Nifty

24,578.35 -346.35
(-1.39%)

Sensex

81,148.22 -1,281.68
( -1.55%)

Bank Nifty

54,940.85 -442.00
( -0.80%)

Nifty IT

37,354.60 -927.95
( -2.42%)

Global Indices

Nasdaq

42,424.12 1,153.74
(2.80%)

Dow Jones

5,865.06 184.15
(3.24%)

Hang Seng

38,283.51 639.25
(1.70%)

Nikkei 225

8,602.92 -2.06
(-0.02%)

Forex

USD-INR

85.41 0.03
(0.03%)

EUR-INR

96.03 -0.26
(-0.27%)

GBP-INR

113.57 0.08
(0.07%)

JPY-INR

0.59 0.00
(-0.40%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

J B Chemicals & Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

506943

INE572A01036

202.8086013

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

JBCHEPHARM

38.68

24315.22

EPS(TTM)

Face Value()

Div & Yield %

40.38

0.78

Back

J B Chemicals & Pharmaceuticals receives USFDA approval for Bisoprolol Tablets

Apr 18,2025

J B Chemicals & Pharmaceuticals has received approval from United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA), Bisoprolol Tablets USP, 5 mg, and 10 mg, the generic version of Zebeta (Teva), which is indicated in the management of hypertension.

24,578.35 -346.35 (-1.39%)

81,148.22 -1,281.68 ( -1.55%)

54,940.85 -442.00 ( -0.80%)

37,354.60 -927.95 ( -2.42%)

42,424.12 1,153.74 (2.80%)

5,865.06 184.15 (3.24%)

38,283.51 639.25 (1.70%)

8,602.92 -2.06 (-0.02%)

85.41 0.03 (0.03%)

96.03 -0.26 (-0.27%)

113.57 0.08 (0.07%)

0.59 0.00 (-0.40%)